BERLIN (GERMANY) – The European Medicines Agency (EMA) is looking forward to getting approval for the COVID-19 vaccine developed by AstraZeneca and Oxford University on Friday, a spokesman of German’s health ministry said.
EU officials are likely to request clarification from AstraZeneca executives on unexpected delivery problems on Monday afternoon.